MedTrace Logo

Clinical Feasibility of the Myotrace Measurement

NCT05661019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2025-12-09

No results posted yet for this study

Summary

To evaluate the feasibility of the MYOTRACE NRD (Neural Respiratory Drive) index as an aid to assess the respiratory status of a patient (improving or stable versus deteriorating) as compared to a specialist in thoracic medicine's evaluation in a general care setting.

Conditions

  • Respiratory Disease

Interventions

OTHER

Obtain Myotrace measurements

Myotrace measurement equipment, consisting of an application (i.e. non-medical software) running on a Philips laptop, Porti7 data acquisition system and software (Twente Medical Systems International (TMSi), Netherlands) (CE-approved), ECG cables, and three standard ECG (for EMG) electrodes. Also an on the shelf accelerometry sensor and respiration belt (TMSi) are used for the NRD measurement (CE-approved).

Sponsors & Collaborators

  • Philips Medizin Systeme

    collaborator UNKNOWN

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Dr. Schwarz · University of Zurich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2025-01-09
Completion
2025-01-09

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05661019 on ClinicalTrials.gov